WASHINGTON, June 27 (Reuters) - A U.S. advisory panel backed an experimental CryoCor Inc. device to treat a type of abnormal heart rhythm, a Food and Drug Administration spokeswoman said on Wednesday.

Aug 2 (Reuters) - Medical device company CryoCor Inc. said the U.S. Food and Drug Administration has granted pre-market approval for its device for the treatment of right atrial flutter, or abnormal ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

SAN FRANCISCO (MarketWatch) -- CryoCor Inc. said after the closing bell on Thursday it has received notification from the Food and Drug Administration that its pre-market approval application for the ...